The exoS, exoT, exoU and exoY Virulotypes of the Type 3 Secretion System in Multidrug Resistant Pseudomonas aeruginosa as a Death Risk Factor in Pediatric Patients
Pathogens · 22.11.2024 · 13 (12) · 1030
DOI: 10.3390/pathogens13121030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 22.11.2024. Verfasst von Carolina G Nolasco-Romero und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Type III Secretion Systems, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Infantil de México Federico Gómez, Ministry of Health and Assistance (SSA).
Abstract (Originalsprache)
The poor prognosis of infections associated with multidrug-resistant Pseudomonas aeruginosa can be attributed to several conditions of the patient and virulence factors of the pathogen, such as the type III secretion system (T3SS), which presents the ability to inject four effectors into the host cell: ExoS, ExoT, ExoU and ExoY. The aim of this study was to analyze the distribution of exo genes through multiplex polymerase chain reaction in P. aeruginosa strains isolated from patients at a third-level pediatric hospital and their relationships with clinical variables, e.g., the origin of the sample, susceptibility profile and outcome, through a multinomial logistic regression model. A total of 336 bacterial strains were obtained from cystic fibrosis (CF; n = 55) and bloodstream infection (BSI; n = 281) samples, and eleven presence (+)/absence (−) exo virulotype patterns were identified. The virulotype V3 (exoU−/exoS+/exoT+/exoY+) was observed in 64.28%, followed by V1 (exoU+/exoS−/exoT+/exoY+) with 11.60%. Additionally, V2 (exoU+/exoS−/exoT+/exoY−) was present in 11.60%, and V7 (exoU−/exoS+/exoT+/exoY−) was present in 4.17%. The remaining virulotypes (8.33%) identified were clustered in the other virulotype (OV) group (V4, V5, V6, V8, V9, V10 and V11). The clinical records of 100 patients and their outcomes were reviewed. Fifteen patients died (CF = 4; BSI = 11). V2 and V1 were the virulotypes most related to pandrug resistance (PDR), whereas the V1 relative risk of death was determined to be almost four-fold greater than that of V3, followed by V2 and OV. In summary, the virulotypes V1, V2 and CF are related to death. This study highlights the association of T3SS virulotypes with the susceptibility profile, clinical origin and their potential for predicting a poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
- Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11350, Mexico.
- Departamento de Investigación, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
- Departamento de Infectología, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
- Laboratorio de inmunomicrobiología, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11350, Mexico.
- Unidad de Investigación y Diagnóstico en Nefrología y Metabolismo Mineral Óseo, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
ORCID-Profile: Carolina G Nolasco-Romero, Francisco-Javier Prado-Galbarro, Uriel Gomez-Ramirez, Juan Carlos Cancino-Díaz, Beatriz López-Marceliano, Magali Reyes Apodaca, Israel Parra-Ortega, Norma Velázquez-Guadarrama
Förderung
- Hospital Infantil de México Federico Gómez
- Ministry of Health and Assistance (SSA)
Zitieren
APA
Nolasco-Romero, C. G., Prado-Galbarro, F. J., Jimenez-Juarez, R. N., Gomez-Ramirez, U., Cancino-Díaz, J. C., López-Marceliano, B., Apodaca, M. R., Aguayo-Romero, M. A., Rodea, G. E., Pichardo-Villalon, L., Parra-Ortega, I., Santos, F. S., Moreno-Galván, M., & Velázquez-Guadarrama, N. (2024). The exoS, exoT, exoU and exoY Virulotypes of the Type 3 Secretion System in Multidrug Resistant Pseudomonas aeruginosa as a Death Risk Factor in Pediatric Patients. Pathogens, 13(12), 1030. https://doi.org/10.3390/pathogens13121030
Vancouver
Nolasco-Romero CG, Prado-Galbarro FJ, Jimenez-Juarez RN, Gomez-Ramirez U, Cancino-Díaz JC, López-Marceliano B, et al. The exoS, exoT, exoU and exoY Virulotypes of the Type 3 Secretion System in Multidrug Resistant Pseudomonas aeruginosa as a Death Risk Factor in Pediatric Patients. Pathogens. 2024;13(12):1030. doi:10.3390/pathogens13121030
BibTeX
@article{NolascoRomero2024,
author = {Nolasco-Romero, Carolina G and Prado-Galbarro, Francisco-Javier and Jimenez-Juarez, Rodolfo Norberto and Gomez-Ramirez, Uriel and Cancino-Díaz, Juan Carlos and López-Marceliano, Beatriz and Apodaca, Magali Reyes and Aguayo-Romero, Mónica Anahí and Rodea, Gerardo E and Pichardo-Villalon, Lilia and Parra-Ortega, Israel and Santos, Fortino Solórzano and Moreno-Galván, Mónica and Velázquez-Guadarrama, Norma},
title = {The exoS, exoT, exoU and exoY Virulotypes of the Type 3 Secretion System in Multidrug Resistant Pseudomonas aeruginosa as a Death Risk Factor in Pediatric Patients},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {12},
pages = {1030},
doi = {10.3390/pathogens13121030}
}
EUVIMED